Xaira

Xaira is reinventing drug R&D using artificial intelligence to rapidly prototype and test antibody and small molecule tr...

Sequoia

What they do

Problem

Traditional drug discovery and development is slow and expensive, delaying effective antibody and small-molecule therapies.

Solution

Xaira uses AI-driven drug R&D to rapidly prototype and experimentally test antibody and small-molecule candidates for validated disease targets.

Who it's for

Biopharma companies and drug discovery R&D teams developing new therapeutics.